Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 92.84% institutional investors, 3.23% insiders, and 3.93% retail investors. Janus henderson group is the largest institutional shareholder, holding 28.02% of RLMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 92.84% | 3.23% | 3.93% |
| Sector | Healthcare Stocks | 128.69% | 12.02% | -40.72% |
| Industry | Biotech Stocks | 180.58% | 11.62% | -92.20% |
| Idea | Psychedelic Stocks List | 55.91% | 8.49% | 35.60% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 11.06M | 28.02% | $76.89M |
| Vr adviser | 6.84M | 7.90% | $47.36M |
| Blackrock funding, inc. /de | 7.58M | 6.74% | $28.57M |
| Spruce street capital lp | 6.91M | 6.15% | $26.06M |
| Adage capital partners gp | 4.76M | 5.50% | $32.96M |
| Jones hill capital lp | 5.24M | 4.66% | $19.75M |
| Orbimed advisors | 3.63M | 4.19% | $25.13M |
| Vanguard capital management | 4.36M | 3.88% | $16.43M |
| Vanguard group | 1.20M | 3.63% | $5.81M |
| State street | 3.31M | 2.94% | $12.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Spruce street capital lp | 6.91M | 4.14% | $26.06M |
| Jones hill capital lp | 5.24M | 3.35% | $19.75M |
| Stempoint capital lp | 1.46M | 1.74% | $10.10M |
| Ikarian capital | 2.15M | 1.60% | $14.87M |
| Vr adviser | 6.84M | 1.44% | $47.36M |
| Sio capital management | 1.00M | 1.15% | $6.94M |
| Great point partners | 842.11K | 1.10% | $5.83M |
| Knott david m jr | 480.00K | 0.99% | $1.81M |
| Birchview capital, lp | 408.10K | 0.89% | $1.54M |
| Commodore capital lp | 1.43M | 0.59% | $9.86M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 11.06M | 0.04% | 3.79M |
| Franklin resources | 2.25M | 0.00% | 2.25M |
| Vr adviser | 6.84M | 1.44% | 2.00M |
| Jones hill capital lp | 5.24M | 3.35% | 1.58M |
| Balyasny asset management | 1.52M | 0.01% | 1.27M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -2.95M |
| Marshall wace, llp | 603.36K | 0.00% | -1.64M |
| Braidwell lp | - | - | -1.58M |
| Millennium management | 2.36M | 0.01% | -1.55M |
| Orbimed advisors | 3.63M | 0.47% | -1.08M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Franklin resources | 2.25M | 0.00% | 2.25M | $9.38M |
| D. e. shaw | 109.47K | 0.00% | 109.47K | $757.56K |
| Wells fargo & company/mn | 86.26K | 0.00% | 86.26K | $596.94K |
| Price t rowe associates inc /md/ | 77.67K | 0.00% | 77.67K | $538.00K |
| Wellington management group llp | 63.80K | 0.00% | 63.80K | $441.50K |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Smartleaf asset management | -35.00 |
| Larson financial group | -100.00 |
| Golden state equity partners | -200.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 130 | -0.76% | 104,328,676 | 3.06% | 92 | 1.14% | 68 | -20.00% | 35 | 59.09% |
| Jun 30, 2026 | 130 | 20.37% | 101,233,656 | 19.49% | 116 | 1.22% | 85 | 32.81% | 21 | -12.50% |
| Mar 31, 2026 | 36 | -57.14% | 7,826,692 | -84.63% | 19 | 0.08% | 20 | -63.64% | 6 | -45.45% |
| Dec 31, 2025 | 43 | -4.44% | 13,954,173 | 80.30% | 42 | 7.73% | 22 | 37.50% | 8 | -27.27% |
| Sep 30, 2025 | 44 | -8.33% | 7,739,578 | 45.94% | 23 | 9.13% | 16 | -5.88% | 10 | -23.08% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.17M | 3.02% | 989.50K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.17M | 3.02% | 989.50K |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.17M | 2.97% | - |
| Vanguard US Total Market Shares ETF | 851.92K | 2.57% | - |
| iShares Russell 2000 ETF | 2.38M | 2.23% | - |
| Eventide Healthcare & Life Sciences I | 1.86M | 1.74% | 1.02M |
| Franklin Biotechnology Discv A(acc)USD | 1.46M | 1.37% | - |
| Polar Capital Biotech S Inc | 1.27M | 1.19% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.21M | 1.13% | 2.13K |
| State Street® SPDR® S&P® PhrmctlsETF | 1.17M | 1.09% | 32.65K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 09, 2026 | Shenouda Maged | Chief Financial Officer | Buy | $504.84K |
| Sep 10, 2026 | Shenouda Maged | Chief Financial Officer | Buy | $339.15K |
| Sep 09, 2026 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $418.00K |
| Sep 10, 2026 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $410.00K |
| Dec 15, 2025 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $113.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 4 | - |
| 2025 Q4 | 6 | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | 8 | - |
| 2024 Q4 | - | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools